The Clinical Trials Regulatory Framework Working Group of HACRO focuses on monitoring and implementing national and European legislation, including Regulation (EU) 536/2014.Its core mission includes:
- Drafting institutional proposals and feedback on bills under public consultation.
- Addressing practical hurdles and operational bottlenecks across hospitals and university/regional health authority research accounts (ELKE/ELKEA).
Through the institutional participation of the BoD President and the Group Leader in the Hellenic Ministry of Health's dedicated task force, the group ensures direct industry representation to foster an optimized clinical research environment in Greece. |
| CORONIS Research SA |
Ch. Beza |
| Creative Pharma & HR Services |
D. Groubou |
| Exelya Greece |
K. Pateli, A. Argyraki, M. Varsami, Th. Belagras |
| Heads |
S. Kosmidi, R. Filippou |
| ICON |
P. Georgiakakis |
| IQVIA |
V. Vazaiou |
| Medpace |
M. Voutyraki, Th. Chortara, V. Kioumourtzi |
| NEXT CRO |
A. Moschos |
| Optimapharm |
I. Pollali |
| Pharmassist Ltd |
M. Moukouli, G. Kalkounou |
| Phaze SA |
I. Drougka |
| PPD Global |
N. Alexandridis, T. Papageorgiou |
| PSI CRO |
Christos Iskos, P. Gkotsi |
| Syneos Hellas |
E. Malliara |